4564 — OncoTherapy Science Share News
0.000.00%
Table: OncoTherapy Science -Q1 group results
Brief: OncoTherapy Science unit signs research collaboration agreement to accelerate the Cancer Precision Medicine
Table: OncoTherapy Science -2017/18 parent results
Table: OncoTherapy Science -2017/18 group results
Brief: OncoTherapy Science unit says joint development with Japanese Foundation For Cancer Research
Brief: OncoTherapy Science unit says business alliance with Thermo Fisher Scientific
Table: OncoTherapy Science - 9-MTH group results
Table: OncoTherapy Science - 6-MTH group results
Table: OncoTherapy Science -Q1 group results
Brief: OncoTherapy Science says close of peptide vaccine related agreement with ONO PHARMACEUTICAL
Brief: OncoTherapy Science receives patent in Japan
Brief: OncoTherapy Science says business and capital alliance with Theragen Etex
Brief: OncoTherapy Science announces change of president
Table: OncoTherapy Science -9-MTH group results
Brief: OncoTherapy Science says result of phase I clinical trial of OTS103/104 (OCV-C02)
Table: OncoTherapy Science -6-MTH group results
Brief: Onco Therapy Science to start Phase I clinical study for breast cancer patients in U.S.
Table: OncoTherapy Science -Q1 group results
Brief: OncoTherapy Science says first-patient enrollment in Phase I/II clinical study of OTS167